Dr. Tap on Olaratumab in Patients With Soft Tissue Sarcoma

ANNOUNCE: Combination of olaratumab and doxorubicin versus doxorubicin alone in patients with ad...Подробнее

Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue SarcomaПодробнее

Soft Tissue Sarcoma: Role of OlaratumabПодробнее

OS vs PFS with OlaratumabПодробнее

SPAEN Webinar Experiences with olaratumab in soft tissue sarcomas with Robin Jones, UK 201810021606Подробнее

Olaratumab + Doxorubicin for Metastatic Soft-Tissue SarcomaПодробнее

Dr. Tap on Improved Overall Survival With Olaratumab/Doxorubicin CombinationПодробнее

Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue SarcomaПодробнее

Olaratumab Efficacy in Soft-Tissue SarcomaПодробнее

Olaratumab Plus Doxorubicin in Advanced Soft Tissue SarcomaПодробнее

Dr. Philip on Olaratumab for Soft Tissue SarcomaПодробнее